Role of effector cells (CCR7-CD27-) and effector-memory cells (CCR7-CD27+) in drug-induced maculopapular exanthema

International Journal of Immunopathology and Pharmacology

Volumn 23, Issue 2, 2010, Pages 437-447

  Fernandez, T D ^a   Torres, M J ^a   Lopez, S ^a   Antunez, C ^a   Gomez, E ^a   Del Prado, M F ^b   Canto, G ^c   Blanca, M ^a   Mayorga Mayorga, Cristobalina ^a  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b HOSPITAL UNIVERSITARIO INFANTA LEONOR   (Spain)

^c NONE

Author keywords

Allergy; Cell trafficking; Chemokines; Skin; T cells

Indexed keywords

CD27 ANTIGEN; CHEMOKINE RECEPTOR CCR10; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR7; CUTANEOUS T CELL ATTRACTING CHEMOKINE; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

ALLERGIC DISEASE; ANTIGEN EXPRESSION; ARTICLE; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL HOMING; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; PRIORITY JOURNAL; STIMULATION; T LYMPHOCYTE ACTIVATION;

EID: 77955353629     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201002300206     Document Type: Article

References (32)

1. Bigby M. Rates of cutaneous reactions to drugs. Arch Dermatol 2001; 137:765-70.
2. Romano A, Blanca M, Torres MJ, Bircher A, Aberer W, Brockow K, Pichler WJ, Demoly P, ENDA, EAACI. Diagnosis of non-immediate reactions to beta-lactam antibiotics. Allergy 2004; 59:1153-60.
3. Yawalkar N, Egli F, Hari Y, Nievergelt H, Braathen LR, Pichler WJ. Infiltration of cytotoxic T-cells in drug-induced cutaneous eruptions. Clin Exp Allergy 2000; 30:847-55.
4. Torres MJ, Mayorga C, Fernandez TD, Cornejo-Garcia JA, Antunez C, Valenzuela M, Del Prado MF, Rodriguez-Pena R, Blanca M. T-cell assessment in allergic drug reactions during the acute phase according to the time of occurrence. Int J Immunopathol Pharmacol 2006; 19:119-30.
5. Posadas S, Padial A, Torres MJ, et al. Delayed reactions to drugs show a Th1 profile and levels of perforin, granzyme B and Fas-L related to disease severity. J Allergy Clin Immunol 2002; 109:155-61.
6. Fernandez T.D, Mayorga C, Torres MJ, Cornejo-Garcia JA, López S, Chaves P, Rondon C, Blanca M. Cytokine and chemokine expression in the skin from patients with maculopapular exanthema to drugs. Allergy 2008; 63:712-19.
7. Campbell JJ, Haraldsen G, Pan J, et al The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T-cells. Nature 1999; 400:776-80.
8. Moed H, Boorsma DM, Stoof TJ, von Blomberg BM, Bruynzeel DP, Scheper RJ, Gibbs S, Rustemeyer T. Nickel-responding T-cells are CD4+ CLA+ CD45RO+ and express chemokine receptors CXCR3, CCR4 and CCR10. Br J Dermatol 2004; 151:32-41.
9. D'Ambrosio D, Panina-Bordignon P, Sinigaglia F. Chemokine receptors in inflammation: an overview. J Immunol Methods 2003; 273:3-13.
10. Morales J, Homey B, Vicari AP, et al. CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T-cells. PNAS 1999; 96:14470-75.
11. Tapia B, Padial A, Sánchez-Sabaté E, Alvarez-Ferreira J, Morel E, Blanca M, Bellon T. CCL27-CCR10 in drug-induced cutaneous reactions: Involvement in SJS and TEN. J Allergy Clin Immunol 2004; 114:335-40.
12. Flier J, Boorsma DM, van Beek PJ, et al. Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation. J Pathol 2001; 194:398-405.
13. Soler D, Humphreys TL, Spinola SM, Campbell JJ. CCR4 versus CCR10 in human cutaneous Th lymphocyte trafficking. Blood 2003; 101:1677-83.
14. Sallusto F, Lenig D, Foster R, Lipp M, Lanzavecchia A. Two subsets of memory T-lymphocytes with distinct homing potentials and effector functions. Nature 1999; 401:708-12.
15. Campbell JJ, Murphy KE, Kunkel EJ, et al. CCR7 expression and memory T-cell diversity in humans. J Immunol 2001; 166:877-84.
16. Stubbe M, Vanderheyde N, Goldman M, Marchant A. Antigen-specific central memory CD4+ T-lymphocytes produce multiple cytokines and proliferate in vivo in humans. J Immunol 2006; 177:8185-90.
17. Baars PA, Maurice MM, Rep M, Hooibrink B, van Lier RA. Heterogeneity of the circulating human CD4+ T-cell population. Further evidence that the CD4+CD45RA-CD27- T-cell subset contains specialized primed T-cells. J Immunol 1995; 154:17-25.
18. Teraki Y, Shiohara T. IFN-gamma-producing effector CD8+ T cells and IL-10-producing regulatory CD4+ T cells in fixed drug eruption. J Allergy Clin Immunol 2003; 112:609-15
19. Antúnez C, Torres MJ, Mayorga C, Cornejo-García JA, Santamaría-Babi LF, Blanca M. Different cytokine production and activation marker profiles in circulating cutaneous-lymphocyte-associated antigen T-cells from patients with acute or chronic atopic dermatitis. Clin Exp Allergy 2004; 34:559-66.
20. Imai T, Yoshida T, Baba M, Nishimura M, Kakizaki M, Yoshie O. Molecular cloning of a novel T-cell-directed CC chemokine expressed in thymus by signal sequence trap using Epstein-Barr virus vector. J Biol Chem 1996; 271:21514-21.
21. Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA. CD4+CD25high regulatory cells in human peripheral blood. J Immunol 2001; 167:1245-53.
22. Tsuge I, Okumura A, Kondo Y, Itomi S, Kakami M, Kawamura M, Nakajima Y, Komatsubara R, Urisu A. Allergen-specific T-cell response in patients with phenytoin hypersensitivity; simultaneous analysis of proliferation and cytokine production by carboxyfluorescein succinimidyl ester (CFSE) dilution assay. Allergol Int 2007; 56:149-55.
23. Torres MJ, Mayorga C, Cornejo-Garcia JA, Lopez S, Chaves P, Rondon C, Fernandez T, Blanca M. Monitoring non-immediate allergic reactions to iodine contrast media. Clin Exp Immunol 2008; 152:233-8.
24. Fritsch RD, Shen X, Sims GP, Hathcock KS, Hodes RJ, Lipsky PE. Stepwise differentiation of CD4 memory T-cells defined by expression of CCR7 and CD27. J Immunol 2005; 175:6489-97.
25. Takata H, Takiguchi M. Three memory subsets of human CD8+ T-cells differently expressing three cytolytic effector molecules. J Immunol 2006; 177:4330-40.
26. Fritsch RD, Shen X, Illei GG, Yarboro CH, Prussin C, Hathcock KS, Hodes RJ, Lipsky PE. Abnormal differentiation of memory T-cells in Systemic Lupus Erythematosus. Arthritis Rheum 2006; 54:2184-97.
27. Gamadia LE, Remmerswaal EB, Weel JF, Bemelman F, van Lier RA, Ten Berge IJ. Primary immune responses to human CMV: a critical role for IFN-gamma-producing CD4+ T-cells in protection against CMV disease. Blood 2003; 101:2686-92.
28. Powell DJ Jr, Dudley ME, Robbins PF, Rosenberg SA. Transition of late-stage effector T-cells to CD27+ CD28+ tumor-reactive effector memory T-cells in humans after adoptive cell transfer therapy. Blood 2005; 105:241-50.
29. Macallan DC, Wallace D, Zhang Y, De Lara C, Worth AT, Ghattas H, Griffin GE, Beverley PC, Tough DF. Rapid turnover of Effector-Memory CD4+ T-cells in Healthy Humans. J Exp Med 2004; 200:255-60.
30. Tapia B, Morel E, Martín-Díaz MA, Díaz R, Alves-Ferreira J, Rubio P, Padial A, Bellón T. Up-regulation of CCL17, CCL22 and CCR4 in drug-induced maculopapular exanthema. Clin Exp Allergy 2007; 37:704-13.
31. Iellem A, Mariani M, Lang R, Recalde H, Panina-Bordignon P, Sinigaglia F, D'Ambrosio D. Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4(+)CD25(+) regulatory T-cells. J Exp Med 2001; 194:847-53.
32. Cavani A, Nasorri F, Ottaviani C, Sebastiani S, De Pità O, Girolomoni G. Human CD25+ regulatory T-cells maintain immune tolerance to nickel in healthy, nonallergic individuals. J Immunol 2003; 171:5760-68.